Ingenza’s impact

100%success rate producing customer targets using one of our hosts
>20xyield enhancement through innovative cell-line and USP development
>70USP and DSP parameters monitored and optimised during process development (in process control)
20years of successful delivery for companies
12Expertise in 12 different biomanufacturing hosts

Pharma solutions

Biologics

Ingenza’s technology platforms will accelerate your development pathway, from drug discovery, through pre-clinical evaluation towards first in human, providing tailored solutions at each stage that meet your timeline with support for all your process, material and analytical needs.

Learn more

Pharma solutions

Small molecule

We have a 20 year history of success engineering efficient microbial production of natural products and the biocatalytic regio- and enantio-selective synthesis of small molecule pharmaceuticals, chiral synthons and advanced intermediates.

Learn more

Sustainable biotech

Ingenza is committed to deploying truly sustainable bioprocesses to meet the environmental and Net Zero objectives of our customers in every industry sector. We enable biomanufacturing to achieve efficiencies of industrial performance, competitiveness and robustness that reduce costs and waste, helping our customers benefit fully from their sustainable manufacturing initiatives.

Learn more

The latest from our news and resources

Ingenza announces move to purpose-built facility at Edinburgh Technopole

Ingenza is delighted to announce its relocation to The Moubray Building at Edinburgh Technopole, part of the Pioneer Group. The new site is still within the Midlothian Science Zone – a world-leading centre of research excellence in life sciences –…

Continue reading

Webinar – Enzymatic Precision: Advancing Complex Small Molecule Synthesis using Biocatalysis

This webinar highlights the opportunity for the exquisite selectivity of enzymatic biotransformations, conducted in vitro or in vivo, to overcome these challenges of tomorrow’s small molecule pharmaceutical manufacturing.

Continue reading